Free Trial
NASDAQ:PRCT

PROCEPT BioRobotics (PRCT) Stock Price, News & Analysis

PROCEPT BioRobotics logo
$60.58 -2.79 (-4.40%)
Closing price 04:00 PM Eastern
Extended Trading
$61.42 +0.84 (+1.39%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About PROCEPT BioRobotics Stock (NASDAQ:PRCT)

Key Stats

Today's Range
$59.47
$63.45
50-Day Range
$60.60
$88.57
52-Week Range
$45.56
$103.81
Volume
957,153 shs
Average Volume
713,211 shs
Market Capitalization
$3.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$94.29
Consensus Rating
Moderate Buy

Company Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PROCEPT BioRobotics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

PRCT MarketRank™: 

PROCEPT BioRobotics scored higher than 57% of companies evaluated by MarketBeat, and ranked 464th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PROCEPT BioRobotics has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    PROCEPT BioRobotics has only been the subject of 2 research reports in the past 90 days.

  • Read more about PROCEPT BioRobotics' stock forecast and price target.
  • Earnings Growth

    Earnings for PROCEPT BioRobotics are expected to grow in the coming year, from ($1.75) to ($1.27) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PROCEPT BioRobotics is -31.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PROCEPT BioRobotics is -31.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    PROCEPT BioRobotics has a P/B Ratio of 10.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about PROCEPT BioRobotics' valuation and earnings.
  • Percentage of Shares Shorted

    11.02% of the float of PROCEPT BioRobotics has been sold short.
  • Short Interest Ratio / Days to Cover

    PROCEPT BioRobotics has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in PROCEPT BioRobotics has recently decreased by 5.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    PROCEPT BioRobotics does not currently pay a dividend.

  • Dividend Growth

    PROCEPT BioRobotics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.02% of the float of PROCEPT BioRobotics has been sold short.
  • Short Interest Ratio / Days to Cover

    PROCEPT BioRobotics has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in PROCEPT BioRobotics has recently decreased by 5.02%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    PROCEPT BioRobotics has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for PROCEPT BioRobotics this week, compared to 6 articles on an average week.
  • Search Interest

    12 people have searched for PRCT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 6 people have added PROCEPT BioRobotics to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PROCEPT BioRobotics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.40% of the stock of PROCEPT BioRobotics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    89.46% of the stock of PROCEPT BioRobotics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about PROCEPT BioRobotics' insider trading history.
Receive PRCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PROCEPT BioRobotics and its competitors with MarketBeat's FREE daily newsletter.

PRCT Stock News Headlines

Leerink Partnrs Issues Negative Estimate for PRCT Earnings
Q1 EPS Estimate for PROCEPT BioRobotics Reduced by Analyst
New Way To Target 2x Trades Every Monday Morning
No. 1 Stock to Buy for THIS MONDAY Heads up: Tim Bohen’s new algorithm just uncovered a dirt-cheap stock that could DOUBLE or MORE this coming Monday. This powerful algo has already identified Monday moves of 149%, 190%, and even a whopping 536%...
Research Analysts Issue Forecasts for PRCT FY2029 Earnings
Wells Fargo Sticks to Its Buy Rating for PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics (PRCT) Receives a Hold from BTIG
See More Headlines

PRCT Stock Analysis - Frequently Asked Questions

PROCEPT BioRobotics' stock was trading at $80.52 on January 1st, 2025. Since then, PRCT shares have decreased by 24.8% and is now trading at $60.58.
View the best growth stocks for 2025 here
.

PROCEPT BioRobotics Co. (NASDAQ:PRCT) issued its quarterly earnings results on Tuesday, February, 25th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.01. The company earned $68.24 million during the quarter, compared to the consensus estimate of $66.79 million. PROCEPT BioRobotics had a negative trailing twelve-month return on equity of 38.57% and a negative net margin of 50.07%.

PROCEPT BioRobotics (PRCT) raised $126 million in an initial public offering on Wednesday, September 15th 2021. The company issued 5,500,000 shares at $22.00-$24.00 per share.

PROCEPT BioRobotics' top institutional investors include FMR LLC (15.64%), Vanguard Group Inc. (9.85%), Alliancebernstein L.P. (3.36%) and Wellington Management Group LLP (2.86%). Insiders that own company stock include Frederic H Moll, Antal Rohit Desai, Reza Zadno, Morgan Colby Wood, Kevin Waters, Hisham Shiblaq, Alaleh Nouri and Global Investors Lp Viking.
View institutional ownership trends
.

Shares of PRCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PROCEPT BioRobotics investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), SPDR Dow Jones Industrial Average ETF Trust (DIA) and Meta Platforms (META).

Company Calendar

Last Earnings
2/25/2025
Today
3/06/2025
Next Earnings (Estimated)
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PRCT
Fax
N/A
Employees
430
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$94.29
High Stock Price Target
$112.00
Low Stock Price Target
$75.00
Potential Upside/Downside
+55.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-105,900,000.00
Pretax Margin
-50.07%

Debt

Sales & Book Value

Annual Sales
$224.50 million
Price / Cash Flow
N/A
Book Value
$5.56 per share
Price / Book
10.90

Miscellaneous

Free Float
43,103,000
Market Cap
$3.16 billion
Optionable
Optionable
Beta
1.03
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:PRCT) was last updated on 3/6/2025 by MarketBeat.com Staff
From Our Partners